Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Lancering Barhemsys H1 19 ?
Volgen
Becausethey bougth at 1.2 and sell it with more than 40% profit on a few days.
What is the influence of next week's vote (15th of January) on the Brexit for Acacia Pharma, being registered in England ? If we move towards a no deal Brexit, then all shares of GB listed companies may head downwards...
For a fistful of dollars schreef op 8 januari 2019 16:43 :
What is the influence of next week's vote (15th of January) on the Brexit for Acacia Pharma, being registered in England ? If we move towards a no deal Brexit, then all shares of GB listed companies may head downwards...
It seems you only post when we go down. And everytime these vague kinds of negative messages. But if shorting is your way, thats fine. But placing non relevant stupid messages here to get your profit is not. So why is this a stupid remark? Acacia only targets the.... drumroll....US market.
Madebeliefje schreef op 8 januari 2019 17:22 :
[...]
It seems you only post when we go down. And everytime these vague kinds of negative messages. But if shorting is your way, thats fine. But placing non relevant stupid messages here to get your profit is not.
So why is this a stupid remark?
Acacia only targets the.... drumroll....US market.
Yes I dont think Acacia should get much trouble for that. The US government shutdown on FDA approvals did cross my mind for a second though. But current applications should be uneffected by the shutdown.
For a fistful of dollars schreef op 8 januari 2019 16:43 :
What is the influence of next week's vote (15th of January) on the Brexit for Acacia Pharma, being registered in England ? If we move towards a no deal Brexit, then all shares of GB listed companies may head downwards...
It would not be logical or reasonable for the Brexit vote (on 15 January) to have any effect on the stock price of Acacia Pharma. The Brexit vote has nothing to do with the quality of the product and pipeline of Acacia Pharma. What is important for Acacia Pharma is the awaited FDA decision. It is possible that somebody might use the Brexit vote to manipulate price movement in the stock market. But I don't think that it will have any long lasting effect on Acacia Pharma. I have not been able to find any news in the public domain that can explain the present low value of the stock price of Acacia Pharma. If people are selling the stock because of the upcoming Brexit vote, then I think that such line of action is unreasonable. The FDA decision can come any day from now--very unexpectedly. So, one has to be careful.
Investor68 schreef op 8 januari 2019 21:15 :
[...]
It would not be logical or reasonable for the Brexit vote (on 15 January) to have any effect on the stock price of Acacia Pharma. The Brexit vote has nothing to do with the quality of the product and pipeline of Acacia Pharma. What is important for Acacia Pharma is the awaited FDA decision. It is possible that somebody might use the Brexit vote to manipulate price movement in the stock market. But I don't think that it will have any long lasting effect on Acacia Pharma. I have not been able to find any news in the public domain that can explain the present low value of the stock price of Acacia Pharma. If people are selling the stock because of the upcoming Brexit vote, then I think that such line of action is unreasonable. The FDA decision can come any day from now--very unexpectedly. So, one has to be careful.
I think most investors already assume that the FDA will aprove Barhemsys. In that sense, an approval on the 5th of may or before should not increase the stock price either. Yet it will, just like a mere delay in the approval caused the stock to drop by 70%. For barely any stock nowadays does the value truely represent the intrinsic company value. Stocks that pay out dividends are typically getting close, as nobody can argue with the hard cash it pays off. But all stocks are somehow effected by factors that should have absolutely no effect on the company. As for Acacia Pharma, the expected year at which it will assume to make profit is 2022/2023. Athough it is a few more years from now, it is within a reasonable timeframe. If you believe in the company and the product then it doesn't matter what happens to the Brexit, the trade war or the delayed FDA approval. After 2023, the Acacia stock price will be based on the money they are making.
Geduld zql en mooie deugd zijn
Voorbeurs een kooporder van 130 aandelen tegen de marktprijs. Manipulatie naar boven toe? Voor nog geen 200 euro aandelen kopen, dan mag je wel een verdomd goedkope broker hebben wil het zin hebben qua transactiekosten.
Vanwege de brexit? Vooralsnog lijkt het erop dat we gaan openen rond 1.6, maar wel kans dat we verder gaan wegzakken komende weken. We liggen gewoon weer ongeveer op de dalenende trendlijn die al sinds de IPO is ingezet (als je de pieken en dalen eruit haalt gaat je lijn linear een klein beetje naar beneden).
Voorlopig heeft de Brexit niet echt een negatieve invloed op de koers. Nu May de stemming heeft overleeft hoop ik op een stabiel koerspatroon tussen 1.5 en 1.7.
Denk dat de beurs allesbehalve stabiel zal zijn de volgende maanden...
Ik had eergister 12,5% van mijn aandelen verkocht, met het plan die rond 1.4 weer terug te kopen. Helaas staat er nu 13.000 bestens in de bied...mooie timing weer. We gaan vandaag richting de 1.7 in ieder geval. Ben benieuwd of dit weer een tijdelijke opleving is, of dat het tij nu aan het keren is.
Laten we hopen op het laatste. Bestens orders van 13.000 stuks lijkt mij een goed teken. Maar aan de andere kant, 5 mei is nog ver weg. Het kan nog alle kanten op.
Er is positief nieuws over de herkansing van UCB, hopelijk stimuleert dit ook de koers van acacia.
Die order lijkt weer te zijn ingetrokken.
als Novo nog eens afbouwt met een procentje, gaan we weer richting 1.5 en lager; ik maak me geen illusies
Vraagje: wie durft binnen twee maanden zijn inzet verdubbelen?
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
882,77
+0,06%
EUR/USD
1,0718
-0,03%
FTSE 100
8.185,63
+0,47%
Germany40^
18.046,80
-0,39%
Gold spot
2.311,61
-1,04%
NY-Nasdaq Composite
15.983,08
+0,35%
Stijgers
Dalers